Skip to content. | Skip to navigation

Advanced Search…
Personal tools
 
You are here: Home → For Faculty & Staff → Reference Search → 2000 References → Ben Ari et al, Jul 2000, Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone

Ben Ari et al, Jul 2000, Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone

Reference

Ben Ari, J., Gozal, D., Dorio, R. J., Bowman, C. M., Reiff, A., & Walker, S. M.  Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone. Clin.Diagn.Lab Immunol., 7(4): 553-556. (2000).

Abstract

Staphylococcus aureus, a common pulmonary pathogen in cystic fibrosis (CF), produces exotoxins that are extremely potent superantigens. A number of animal studies have shown that superantigens cause pulmonary inflammation, but the possible role of superantigens in CF has not been investigated. The present study assessed possible differences between control and CF B cells in presenting superantigens to T cells. Immortalized B-cell lines were used as superantigen-presenting cells to avoid environmental influences (e.g., infection or antibiotics) common to freshly isolated cells. The results show that CF B-cell lines presented a staphylococcal superantigen to the immortalized T-cell line (Jurkat) as effectively as did control B-cell lines as measured by interleukin-2 production. However, in contrast to the case for control B-cell lines, dexamethasone did not inhibit CF B-cell lines from presenting superantigen. The resistance of superantigen-presenting CF B cells to corticosteroids suggests that the pulmonary response to superantigens may be poorly regulated in CF, leading to an exaggerated inflammatory response to S. aureus
Document Actions
Personal tools